Apelin-Receptor (APJ) Antagonists
A series of molecule compounds that inhibit an alternative (non-VEGF) angiogenic pathway overexpressed in a variety of cancers
Published: 27th April 2022

Patents
- US Provisional Patent Application 63/287,053 filed December 7, 2021.
IP Status
- Provisional patent
- Patent application submitted
Seeking
- Development partner
- Licensing
- Commercial partner